Physician profile
Joel Forman
NPI 1447227111
$64,441.41
in general payments reported to CMS, 2019-2025
17 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $15K · 2021: $6,797 · 2022: $6,418 · 2023: $630 · 2024: $196 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $600 · Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $600.00 |
| Food and Beverage | $370.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $24,886.03 | 2019-2023 | |
| Pfizer INC. | $21,502.96 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $16,285.96 | 2019-2023 | |
| Amgen INC. | $390.86 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $382.14 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $278.69 | 2019-2020 | |
| Amarin Pharma, INC. | $204.83 | 2019-2022 | |
| Heartflow, INC. | $144.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.46 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $73.48 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $57.73 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $33.92 | 2019 | |
| Ceribell, INC. | $31.63 | 2024 | Pocket Eeg Device |
| Boston Scientific Corporation | $30.24 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $18.47 | 2024 | Verquvo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $17.57 | 2022 | |
| Astellas Pharma US INC | $16.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Forman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.